Ping Liu

Dr. Ping Liu


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 October 2021 in Cell Biology International
Verified
Journal Article
Open access
PDF file
XKXiaoping Ke
Xiaoping Ke
LLLi Li
Li Li
JLJingwei Li
Jingwei Li
MZMengyu Zheng
Mengyu Zheng
PLPing Liu
Ping Liu
Deletion and mutation of phosphatase and tensin homolog deleted on chromosome10 (PTEN) are closely associated with the occurrence of tumors. Tumor suppressor gene PTEN mutation plays an important role in the pathogenesis of ovarian cancer. However, it has been unclear whether it can regulate the senescence of ovarian cancer cells. We speculated that PTEN might inhibit the occurrence and development of ovarian cancer by promoting the expression of P21. We found that the expression of TRIM39 in human ovarian cancer was significantly diminished. In SKOV3 cells treated with naringin, the expression of TRIM39, which binds P21 and inhibits P21 degradation, was significantly elevated. Real‐time polymerase chain reaction (PCR), Western blot, and immunofluorescence were used to detected the expression of PTEN, p21, and TRIM39, β‐galactosidase Staining was used to detect cell senescence, Ki67 staining was used to observe cell proliferation, Trim39 interference or overexpression assay was used to detect its function. We speculated that PTEN might promote SKOV3 cell senescence by increasing TRIM39 expression and decreasing P21 degradation. Furthermore, by interfering with TRIM39 in SKOV3 cells, we found that the expression of P21 was downregulated, and the number of senescent SKOV3 cells decreased. With overexpression of TRIM39 in SKOV3 cells, the expression of P21 was upregulated, and the number of senescent SKOV3 cells increased. When naringin, a PTEN agonist, was added to SKOV3 cells in which TRIM39 protein was interfered with, the expression of P21 was significantly lower than that in the control group, and the number of senescent ovarian cancer cells was significantly diminished. Our results indicated that PTEN maintained the stability of P21 and decreased the degradation of P21 by increasing TRIM39 expression, thus promoting the senescence of SKOV3 cells, and PTEN maintained the stability of p21 and promoted the aging of SKOV3 cells might be a novel therapeutic target for ovarian cancer.

24 September 2025 in Frontiers in Medicine
Verified
Journal Article
Open access
PDF file
HDHuan Dong
Huan Dong
XCXiaolei Chi
Xiaolei Chi
YLYe Liu
Ye Liu
WLWenjuan Liu
Wenjuan Liu
XCXinliang Chen
Xinliang Chen
PLPing Liu
Ping Liu
Background: Pelvic floor muscle weakness (PFMW) is a significant postpartum complication linked to pelvic floor dysfunction. PFMW impairs quality of life and requires early intervention. This study aimed to develop and validate a clinical prediction model for early postpartum PFMW in primiparous women after vaginal delivery. Methods: This retrospective cohort study was conducted at a tertiary maternity hospital in Shanghai, China. Primiparous women with vaginal deliveries (July 2021–December 2023) were enrolled. Participants were assessed for PFMW using pelvic floor surface electromyography (sEMG) via the Glazer protocol at 42–90 days postpartum. Maternal and obstetric predictors were analyzed via univariable and multivariable logistic regression to construct a nomogram. Model performance was evaluated using concordance statistics (C-statistics), calibration curves, and decision curve analysis in both the training ( n = 2,465) and validation ( n = 1,049) cohorts. Internal validation was performed via ten-fold cross-validation. Results: Among 3,514 enrolled women, PFMW occurred in 25.55% (898/3,514), with comparable baseline characteristics between cohorts (age, pre-pregnancy BMI; P > 0.05). Multivariable analysis revealed five independent predictors: maternal age (OR 1.156, 95% CI 1.116–1.999), gestational weight gain (OR 1.146, 95% CI 1.116–1.178), instrumental delivery (forceps: OR 1.904, 95% CI 1.336–2.714), prolonged second stage of labor (OR 1.026, 95% CI 1.022–1.029), and infant weight (OR 1.003, 95% CI 1.002–1.003). The nomogram demonstrated strong discrimination [C-statistic: 0.866 (95% CI 0.850–0.882) in the training cohort; 0.870 (0.819–0.903) in the validation cohort] and good calibration. Decision curve analysis confirmed the clinical utility across threshold probabilities (0–0.3). Conclusion: This study established a validated nomogram integrating maternal and obstetric factors to predict early postpartum PFMW in primiparous women after vaginal delivery. This tool may aid in the early identification of high-risk individuals, enabling targeted rehabilitation to mitigate long-term pelvic floor dysfunction.

1 April 2025 in Journal of Multidisciplinary Healthcare
Verified
Journal Article
Open access
PDF file
HDHuan Dong
Huan Dong
YLYe Liu
Ye Liu
XWXianjing Wang
Xianjing Wang
PLPing Liu
Ping Liu
Purpose: The fat-to-muscle mass ratio (FMR) is a novel anthropometric parameter that integrates the antagonistic effects of fat and muscle mass. The current study aimed to examine the associations between total and region-specific FMR with the prevalence of self-reported infertility in US women. Methods: US women aged 20 to 44 years from the 2013– 2018 National Health and Nutrition Examination Survey were included. Total, trunk, arm, and leg FMR were calculated from fat mass and muscle mass in the corresponding body part by dual-energy X-ray absorptiometry. Binary logistic regression, restricted cubic spline analysis and subgroup analysis were primarily used for statistical analyses. Results: Infertility prevalence was 12.77% among the 1958 women included. Arm and leg FMR were not associated with infertility prevalence, while the odds ratio and 95% confidence intervals for infertility by each 0.1 point increase in trunk and total FMR were 1.19 (1.07– 1.33) and 1.16 (1.04– 1.30), respectively. Restricted cubic spline analysis indicated a positive and linear relationship between trunk or total FMR and infertility prevalence. Subgroup analysis consistently demonstrated that the associations between trunk or total FMR with infertility prevalence were more pronounced in women without a pregnancy history than in those with a pregnancy history. The receiver-operating characteristic curves indicated that the trunk FMR outperformed total, arm, and leg FMR in discriminating infertility from women without infertility. Conclusion: Trunk and total FMR, rather than arm or leg FMR, were associated with an increased risk of infertility in US women, especially those without a prior pregnancy history.

1 December 2023 in Translational Cancer Research
Verified
Journal Article
Open access
PDF file
YZYuan Zhang
Yuan Zhang
LLLi Li
Li Li
XKXiao-Ping Ke
Xiao-Ping Ke
PLPing Liu
Ping Liu
Background: Endometrial cancer (EC) is one of the most common malignancies among women. To improve the prognosis and treatment of EC, finding out a phosphatase and tensin homolog deleted on chromosome 10 (PTEN)-associated prognostic signature would be beneficial. Methods: EC clinical data, genetic mutation data, and transcriptome data were downloaded from The Cancer Genome Atlas (TCGA) database. To clarify the specific PTEN-associated signature, cox regression analyses were performed. The clinical value of the selected signature on the overall survival (OS) and the secretoglobin family 2A member 1 (SCGB2A1)-independent analysis, immune and functional analysis were investigated respectively. Results: Five hundred and fourteen EC samples were screened and PTEN mutation occupied 57%. Enrichment analysis indicated that mutant-type PTEN was enriched for pathways related to the upregulated human T-cell leukemia virus-1 (HTLV-1) infection and estrogen signaling pathway. SCGB2A1 was identified by cox regression analysis. Immune analysis exhibited significant immune infiltration with higher expression of T cells, B cells, and macrophage groups. Immune-checkpoint transcripts CD274 molecule (CD274), and cytotoxic T-lymphocyte associated protein 4 (CTLA4), hepatitis A virus cellular receptor 2 (HAVCR2), lymphocyte activation gene 3 (LAG3), programmed cell death 1 (PDCD1), PDCD1 ligand 2 (PDCD1LG2), T cell immunoreceptor with immunoglobulin and immunoreceptor tyrosine-based inhibition motif domains (TIGIT), and sialic acid binding immunoglobulin like lectin 15 (SIGLEC15) were discovered statistically different. In addition, the low-SCGB2A1 group had worse OS than the high-SCGB2A1 group. SCGB2A1 showed significant area under the curve (AUC) values in a time-dependent receiver operating characteristic (ROC) analysis. Prevalence of microsatellite instability (MSI) was detected and SCGB2A1 showed a negative correlation with EC. Immune checkpoint blockade (ICB) response indicated a worse immune response in the low-SCGB2A1 group. The distribution of one-class linear regression (OCLR) scores reflected the negative correlation between messenger RNA expression-based stemness index (mRNAsi) and prognostic gene expression. Furthermore, several SCGB2A1-related signaling pathways in EC were identified. Conclusions: SCGB2A1 is a prognostic immunometabolic signature for patients with EC, which may help improve the prognosis and therapeutic effect.

7 April 2026 in Frontiers in Medicine
Verified
Journal Article
Open access
PDF file
RXRui-Hong Xue
Rui-Hong Xue
JLJuan Li
Juan Li
YLYun-Xia Li
Yun-Xia Li
ZGZhao-Ying Gu
Zhao-Ying Gu
DTDan Tang
Dan Tang
PLPing Liu
Ping Liu
Objective: Early medical abortion (EMA) with mifepristone-misoprostol commonly relies on subjective metrics (e.g., last menstrual period-derived gestational age) for failure risk assessment, which may introduce uncertainty. This retrospective study aimed to identify objective predictors of EMA failure and explore the utility of different gestational sac size metrics for clinical risk stratification. Study design: Early pregnancy outpatients who underwent medical abortion with the mifepristone-misoprostol regimen at Karamay Central Hospital (Xinjiang, China) from December 2024 to July 2025 were included in our study. EMA failure was defined as the need for surgical evacuation. Analyses included univariate assessment, logistic regression, and performance evaluation of gestational sac size metrics. Results: After exclusion, 159 women were included in the final analyses. The overall EMA success rate was 89.31% (142/159). Maternal age ≥35 years was associated with higher failure risk (OR = 2.82, 95% CI, 1.01–7.89, p = 0.048). Gestational sac size emerged as an important objective correlate of EMA failure; among five assessed metrics (ellipsoid volume, maximum diameter, mean diameter, sum of three diameters, triple product of diameters), the triple product of diameters showed the highest correlation with failure ( r = 0.316) and a significant association with failure risk (OR per 1,000 mm 3 increase = 1.08, 95% CI, 1.03–1.14, p = 0.003). The triple product model demonstrated good discrimination, with an area under the curve (AUC) of 0.78 (95% CI, 0.68–0.88). Calibration was adequate (Hosmer-Lemeshow p = 0.62), and internal validation using bootstrap resampling confirmed stable performance (optimism-corrected AUC 0.76, 95% CI, 0.65–0.86). Its optimal cutoff (3648) yielded sensitivity = 0.765, specificity = 0.688, and Youden Index = 0.453. Fetal heart activity, embryonic bud presence, and parity were not significantly linked to failure (all p > 0.05). Conclusion: Gestational sac size is an important objective indicator for predicting mifepristone-misoprostol EMA failure, and among various gestational sac size metrics, the triple product of diameters demonstrates the highest predictive value.

9 May 2026 in Discover Oncology
Verified
Journal Article
Open access
YLYu Liu
Yu Liu
YYYu Yang
Yu Yang
CWChun-Chun Wang
Chun-Chun Wang
WZWen-Ying Zhang
Wen-Ying Zhang
LCLei Cao
Lei Cao
PLPing Liu
Ping Liu
Ovarian cancer (OV) is characterized by uncontrolled malignant proliferation of ovarian tissue. N-acetyltransferase 10(NAT10) enhances mRNA stability through N4-acetylcytidine (ac4C) modification. This study investigates the oncogenic role of NAT10-mediated ac4C modification in OV and to identify its critical downstream target(s). NAT10 expression was profiled in 18 paired OV and adjacent normal tissues by RT-qPCR and in two OV cell lines (TOV-112D and ES-2) versus a normal control by RT-qPCR and Western blot. ac4C modification was verified by acRIP-qPCR and acRIP-qPCR. Functional assays (CCK-8, Transwell migration and invasion) assessed the impact of NAT10 knockdown. RNA immunoprecipitation (RIP) and dual-luciferase reporter assays mapped the NAT10-NLRP3 interaction and ac4C-dependent regulation of NLRP3 3'UTR stability. Rescue experiments evaluated whether NLRP3 overexpression could reverse the phenotype caused by NAT10 silencing. NAT10 mRNA and protein were significantly up-regulated in OV tissues and cell lines (P < 0.001), with an ROC-derived AUC of 0.865 indicating robust diagnostic potential. Knockdown of NAT10 markedly reduced proliferation, migration, and invasion of OV cells. Mechanistically, NAT10 bound directly to NLRP3 mRNA and augmented ac4C modification within its 3'UTR, thereby extending NLRP3 transcript half-life. Luciferase assays confirmed that mutation of ac4C sites abolished NAT10-mediated regulation. Restoration of NLRP3 expression fully rescued the proliferative and metastatic capacity suppressed by NAT10 depletion. Our findings establish NAT10-mediated ac4C modification of NLRP3 mRNA as a novel epigenetic axis that accelerates OV aggressiveness.Targeting the NAT10-NLRP3 pathway may offer a promising therapeutic avenue for patients with advanced ovarian cancer.